Changes to Average Survival of Patients With Amyotrophic Lateral Sclerosis (1995–2018)

医学 肌萎缩侧索硬化 利鲁唑 比例危险模型 危险系数 纪元(天文学) 生存分析 队列 人口 儿科 多元分析 内科学 置信区间 疾病 星星 物理 环境卫生 天文
作者
Rosario Vasta,Filippo De Mattei,Salvatore Tafaro,Antonio Canosa,Umberto Manera,Maurizio Grassano,Francesca Palumbo,Sara Cabras,Enrico Matteoni,Francesca Di Pede,Grazia Zocco,Giorgio Pellegrino,Emilio Minerva,Daniela Pascariu,Barbara Iazzolino,Stefano Callegaro,Giuseppe Fuda,Paolina Salamone,Fabiola De Marchi,Letizia Mazzini
出处
期刊:Neurology [Lippincott Williams & Wilkins]
卷期号:104 (8) 被引量:1
标识
DOI:10.1212/wnl.0000000000213467
摘要

The average survival of patients with amyotrophic lateral sclerosis (ALS) ranges from 2 to 5 years from symptom onset. However, it remains unclear whether this estimate has improved over time. The objective of this study was to analyze the survival trend of a large population-based cohort of patients with ALS over a 24-year period. Patients from the Piemonte and Valle d'Aosta registry for ALS (PARALS) were categorized into the first (1995-2002), second (2003-2010), or third (2011-2018) epoch based on their diagnosis date. Survival was defined as the time from diagnosis to death, tracheostomy, or censoring date. A Cox proportional hazard model was developed with diagnosis epoch as the primary variable of interest, adjusted for sex, site of onset, age at onset, diagnostic delay, forced vital capacity at diagnosis, Δbody mass index from onset to diagnosis, noninvasive mechanical ventilation use, gastrostomy use, and site of follow-up. A subset analysis comparing the 2007-2012 and 2013-2018 cohorts was conducted, incorporating riluzole prescription, genetics, and preslope category as additional covariates. A total of 3,134 patients were included, evenly distributed across the 3 epochs (990, 1,023, and 1,121, respectively). The median survival remained stable during the first and second epoch (18.6 months vs 18.3 months) but improved during the third epoch (20.1 months; p = 0.0041), with a hazard ratio (HR) of 0.76 (95% CI 0.67-0.87, p = 0.00003). In the subset analysis, the most recent epoch (2013-2018) showed a continued survival advantage (HR 0.77, 95% CI 0.65-0.90). Of interest, the survival benefit was only evident among intermediate progressors (HR 0.60, 95% CI 0.45-0.80). In the PARALS, ALS survival increased over time. In a subset analysis, the beneficial effect of the epoch was only evident among intermediate progressors. The improvement in multidisciplinary care provided by tertiary centers may be one possible explanation for this finding, although further dedicated studies are needed to confirm this hypothesis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
lemon发布了新的文献求助10
1秒前
Nole的应助被谭代涛采纳,获得10
3秒前
baozeNG完成签到,获得积分10
3秒前
活力雨竹发布了新的文献求助10
3秒前
Fishball完成签到,获得积分10
5秒前
大个的应助被月下独酌采纳,获得10
5秒前
Frank完成签到,获得积分10
8秒前
沉静的鸭子完成签到,获得积分10
8秒前
9秒前
Ksharp10完成签到,获得积分10
9秒前
honey完成签到 ,获得积分10
9秒前
赘婿的应助被眯眯眼的猫咪采纳,获得10
10秒前
11秒前
zy完成签到,获得积分10
12秒前
12秒前
demonapple12完成签到,获得积分10
12秒前
July完成签到,获得积分10
12秒前
MooN发布了新的文献求助10
12秒前
爆米花的应助被lemon采纳,获得10
13秒前
酷波er的应助被xx采纳,获得10
14秒前
14秒前
李李李发布了新的文献求助10
14秒前
aajhajkahna的应助被青枫采纳,获得10
16秒前
学术混子完成签到 ,获得积分10
18秒前
ninini发布了新的文献求助30
19秒前
吴彦祖发布了新的文献求助100
21秒前
英俊的铭的应助被2231131采纳,获得10
22秒前
丘比特的应助被陈jiajia采纳,获得10
23秒前
天天快乐的应助被蓝天采纳,获得10
24秒前
25秒前
田様的应助被33采纳,获得10
25秒前
28秒前
29秒前
29秒前
30秒前
31秒前
糊糊完成签到,获得积分10
32秒前
李李李完成签到,获得积分20
32秒前
ding的应助被ninini采纳,获得10
33秒前
高分求助中
(应助此贴封号)通过应助OA文献获取积分 10000
Rosenblum, Global Change Biology 800
The Dawn of Philology 520
Organizational Behavior 510
Management and the Arts 510
Production Logging: Theoretical and Interpretive Elements 400
A primer on partial least squares structural equation modeling (PLS-SEM) (4th ed.) 310
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 内科学 物理 有机化学 化学工程 生物化学 复合材料 光电子学 细胞生物学 心理学 量子力学 催化作用 物理化学 电极
热门帖子
关注 科研通微信公众号,转发送积分 7819510
求助须知:如何正确求助?哪些是违规求助? 9347304
关于积分的说明 20540132
捐赠科研通 7411892
什么是DOI,文献DOI怎么找? 3332363
关于科研通互助平台的介绍 2478418
邀请新用户注册赠送积分活动 2352018